Cargando…

Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis

High thyroid stimulating hormone (TSH) levels may stimulate papillary thyroid cancer (PTC) cell proliferation; however, the relationship between TSH levels and PTC risk remains controversial. We aim to ascertain the association through a meta-analysis. Literature searches were conducted in PubMed, E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Bin, Gu, Shu-Yan, Zhou, Ning-Ming, Jiang, Jun-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426723/ https://www.ncbi.nlm.nih.gov/pubmed/37588997 http://dx.doi.org/10.1515/biol-2022-0671

Ejemplares similares

Relationship Between Thyroid-Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients
por: Liu, Riming, et al.
Publicado: (2017)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Sensitivity to thyroid hormone indices are associated with papillary thyroid carcinoma in Chinese patients with thyroid nodules
por: Sun, Jie, et al.
Publicado: (2023)

Comparative study on operative trauma between microwave ablation and surgical treatment for papillary thyroid microcarcinoma
por: Xu, Bin, et al.
Publicado: (2018)

Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy
por: Ma, Yuqin, et al.
Publicado: (2017)

Expression and Clinical Significance of Thyroid-stimulating hormone receptor in the Subtypes of Papillary thyroid carcinomas
por: Shen, Wei, et al.
Publicado: (2023)

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor
por: Zheng, Haitao, et al.
Publicado: (2016)

Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma
por: Igata, Motoyuki, et al.
Publicado: (2016)

Thyroid Hormone Resistance With Concurrent Papillary Thyroid Cancer
por: Pahwa, Dhivya, et al.
Publicado: (2021)

Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
por: Babić Leko, Mirjana, et al.
Publicado: (2021)

A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk
por: Lai, Xingjian, et al.
Publicado: (2017)

The association between thyroid-stimulating hormone and thyroid nodules, goiter and thyroid antibody positivity
por: Li, Shaohan, et al.
Publicado: (2023)

The Relationships between Thyroid Hormones and Thyroid-stimulating Hormone with Lipid Profile in Euthyroid Men
por: Chin, Kok-Yong, et al.
Publicado: (2014)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery
por: Shuai, Jin-Hao, et al.
Publicado: (2023)

Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level
por: Choi, Wona, et al.
Publicado: (2021)

Development and validation of the nomogram based on ultrasound, thyroid stimulating hormone, and inflammatory marker in papillary thyroid carcinoma: a case-control study
por: Tang, Zhong-Wei, et al.
Publicado: (2023)

Hyponatremia after Thyroid Hormone Withdrawal in a Patient with Papillary Thyroid Carcinoma
por: Jo, Hyo Jin, et al.
Publicado: (2014)

Association of Preoperative Serum Thyroid-stimulating Hormone Levels with Thyroid Cancer in Patients with Nodular Thyroid Disease
por: Khan, Muhammad Aleem, et al.
Publicado: (2017)

Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults
por: Ito, Yasuhiro, et al.
Publicado: (2022)

Association between Thyroiditis and Multifocality in Papillary Thyroid Carcinoma
por: Dedivitis, Rogério Aparecido, et al.
Publicado: (2021)

Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer
por: Liu, Yushu, et al.
Publicado: (2022)

Neonatal thyroid screening: Relationship between cord blood thyroid stimulating hormone levels and thyroid stimulating hormone in heel prick sample on 4(th) to 7(th) day-of-life
por: Seth, Anju, et al.
Publicado: (2014)

Neonatal thyroid screening: Relationship between cord blood thyroid stimulating hormone levels and thyroid stimulating hormone in heel prick sample on 4(th) to 7(th) day-of-life
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2015)

Thyroid-stimulating hormone levels in children from Chernobyl.
por: Quastel, M R, et al.
Publicado: (1997)

Genetic associations with neonatal thyroid stimulating hormone levels
por: Alul, Farah Y., et al.
Publicado: (2013)

Calcification Patterns in Papillary Thyroid Carcinoma are Associated with Changes in Thyroid Hormones and Coronary Artery Calcification
por: Ha, Jeonghoon, et al.
Publicado: (2018)

Association Between Autoantibodies Against Thyroid Stimulating Hormone Receptor and Thyroid Diseases
por: Latifi-Pupovci, Hatixhe
Publicado: (2014)

Serum levels of thyroid hormones and thyroid stimulating hormone in patients with biliogenic and hyperlipidaemic acute pancreatitis: Difference and value in predicting disease severity
por: Yang, Ning, et al.
Publicado: (2016)

Thyroid Stimulating Hormone Receptor
por: Tuncel, Murat
Publicado: (2017)

Synchronous primary hyperparathyroidism, follicular thyroid carcinoma, and papillary thyroid carcinoma
por: Dai, Dong-Jun, et al.
Publicado: (2019)

C-reactive protein and thyroid-stimulating hormone levels as risk factors for hypothyroidism in patients with subacute thyroiditis
por: Tang, Chenjia, et al.
Publicado: (2021)

Correction: Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults
por: Ito, Yasuhiro, et al.
Publicado: (2022)

The Difference in Thyroid Stimulating Hormone Levels between Differentiated Carcinoma and Benign Enlargement
por: Rianto, Bambang Udji Djoko, et al.
Publicado: (2020)

Association Between Serum Thyroid-Stimulating Hormone Levels and Salivary Microbiome Shifts
por: Dong, Ting, et al.
Publicado: (2021)

Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis
por: Tang, Qizhi, et al.
Publicado: (2022)

Characterization of Papillary Thyroid Microcarcinomas Using Sonographic Features in Malignant Papillary Thyroid Cancer: A Retrospective Analysis
por: Gu, Wei-jun, et al.
Publicado: (2015)

Patients with papillary thyroid carcinoma associated with high stimulated serum calcitonin levels
por: Unluhizarci, Kursad, et al.
Publicado: (2017)

Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis
por: Zhang, Zhen-Zhen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kp65eukui6p4dfcacqvtirbrg8